Fedorova O - Search Results

1

Attenuation of p53 mutant as an approach for treatment Her2-positive cancer.

Fedorova O, Daks A, Shuvalov O, Kizenko A, Petukhov A, Gnennaya Y, Barlev N. Fedorova O, et al. Cell Death Discov. 2020 Oct 10;6:100. doi: 10.1038/s41420-020-00337-4. eCollection 2020. Cell Death Discov. 2020. PMID: 33083021 Free PMC article. Review.

2

Effect of ubiquitination on peptidase activities of proteasomes in genotoxic stress.

Moiseeva TN, Fedorova OA, Tsimokha AS, Mittenberg AG, Barlev NA. Moiseeva TN, et al. Among authors: fedorova oa. Dokl Biochem Biophys. 2010 Nov-Dec;435:307-11. doi: 10.1134/S1607672910060074. Epub 2010 Dec 24. Dokl Biochem Biophys. 2010. PMID: 21184300 No abstract available.

3

KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.

Lezina L, Aksenova V, Ivanova T, Purmessur N, Antonov AV, Tentler D, Fedorova O, Garabadgiu AV, Talianidis I, Melino G, Barlev NA. Lezina L, et al. Among authors: fedorova o. Cell Death Differ. 2014 Dec;21(12):1889-99. doi: 10.1038/cdd.2014.108. Epub 2014 Aug 15. Cell Death Differ. 2014. PMID: 25124555 Free PMC article.

4

Current genome editing tools in gene therapy: new approaches to treat cancer.

Shuvalov O, Petukhov A, Daks A, Fedorova O, Ermakov A, Melino G, Barlev NA. Shuvalov O, et al. Among authors: fedorova o. Curr Gene Ther. 2015;15(5):511-29. doi: 10.2174/1566523215666150818110241. Curr Gene Ther. 2015. PMID: 26282844 Review.

5

KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.

Lezina L, Aksenova V, Fedorova O, Malikova D, Shuvalov O, Antonov AV, Tentler D, Garabadgiu AV, Melino G, Barlev NA. Lezina L, et al. Among authors: fedorova o. Oncotarget. 2015 Sep 22;6(28):25843-55. doi: 10.18632/oncotarget.4584. Oncotarget. 2015. PMID: 26317544 Free PMC article.

6

[NEGATIVE REGULATORS OF TUMOR SUPPRESSOR P53 IN THE CONTEXT OF ANTICANCER THERAPY].

Shuvalov OY, Fedorova OA, Petukhov AV, Daks AA, Vasilieva EA, Grigorieva TA, Ivanov GS, Barlev NA. Shuvalov OY, et al. Among authors: fedorova oa. Tsitologiia. 2015;57(12):847-54. Tsitologiia. 2015. PMID: 26995961 Review. Russian.

7

[TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].

Daks AA, Petukhov AV, Shuvalov OY, Vasilieva EA, Melino G, Barlev NA, Fedorova OA. Daks AA, et al. Among authors: fedorova oa. Tsitologiia. 2015;57(12):876-9. Tsitologiia. 2015. PMID: 26995965 Russian.

8

Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.

Clausse V, Goloudina AR, Uyanik B, Kochetkova EY, Richaud S, Fedorova OA, Hammann A, Bardou M, Barlev NA, Garrido C, Demidov ON. Clausse V, et al. Among authors: fedorova oa. Cell Death Dis. 2016 Apr 14;7(4):e2195. doi: 10.1038/cddis.2016.96. Cell Death Dis. 2016. PMID: 27077811 Free PMC article.

9

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.

Shuvalov O, Petukhov A, Daks A, Fedorova O, Vasileva E, Barlev NA. Shuvalov O, et al. Among authors: fedorova o. Oncotarget. 2017 Apr 4;8(14):23955-23977. doi: 10.18632/oncotarget.15053. Oncotarget. 2017. PMID: 28177894 Free PMC article. Review.

10

E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells.

Daks A, Petukhov A, Fedorova O, Shuvalov O, Merkulov V, Vasileva E, Antonov A, Barlev NA. Daks A, et al. Among authors: fedorova o. Genes Cancer. 2016 Nov;7(11-12):383-393. doi: 10.18632/genesandcancer.123. Genes Cancer. 2016. PMID: 28191284 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters